These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17611706)

  • 1. Mild prevalent and incident vertebral fractures are risk factors for new fractures.
    Roux C; Fechtenbaum J; Kolta S; Briot K; Girard M
    Osteoporos Int; 2007 Dec; 18(12):1617-24. PubMed ID: 17611706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
    Roux C; Reginster JY; Fechtenbaum J; Kolta S; Sawicki A; Tulassay Z; Luisetto G; Padrino JM; Doyle D; Prince R; Fardellone P; Sorensen OH; Meunier PJ
    J Bone Miner Res; 2006 Apr; 21(4):536-42. PubMed ID: 16598373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.
    Genant HK; Jergas M; Palermo L; Nevitt M; Valentin RS; Black D; Cummings SR
    J Bone Miner Res; 1996 Jul; 11(7):984-96. PubMed ID: 8797120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS).
    Ferrar L; Roux C; Felsenberg D; Glüer CC; Eastell R
    Osteoporos Int; 2012 Jan; 23(1):59-65. PubMed ID: 21732219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosis.
    Roux C; Fechtenbaum J; Kolta S; Said-Nahal R; Briot K; Benhamou CL
    J Bone Miner Res; 2010 Feb; 25(2):362-8. PubMed ID: 19594302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
    Seeman E
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures.
    Johansson H; Odén A; McCloskey EV; Kanis JA
    Osteoporos Int; 2014 Jan; 25(1):235-41. PubMed ID: 23974856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia.
    Seeman E; Devogelaer JP; Lorenc R; Spector T; Brixen K; Balogh A; Stucki G; Reginster JY
    J Bone Miner Res; 2008 Mar; 23(3):433-8. PubMed ID: 17997711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos).
    Papaioannou A; Joseph L; Ioannidis G; Berger C; Anastassiades T; Brown JP; Hanley DA; Hopman W; Josse RG; Kirkland S; Murray TM; Olszynski WP; Pickard L; Prior JC; Siminoski K; Adachi JD
    Osteoporos Int; 2005 May; 16(5):568-78. PubMed ID: 15517191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.
    Delmas PD; Genant HK; Crans GG; Stock JL; Wong M; Siris E; Adachi JD
    Bone; 2003 Oct; 33(4):522-32. PubMed ID: 14555255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS).
    Roy DK; O'Neill TW; Finn JD; Lunt M; Silman AJ; Felsenberg D; Armbrecht G; Banzer D; Benevolenskaya LI; Bhalla A; Bruges Armas J; Cannata JB; Cooper C; Dequeker J; Diaz MN; Eastell R; Yershova OB; Felsch B; Gowin W; Havelka S; Hoszowski K; Ismail AA; Jajic I; Janott I; Johnell O; Kanis JA; Kragl G; Lopez Vaz A; Lorenc R; Lyritis G; Masaryk P; Matthis C; Miazgowski T; Gennari C; Pols HA; Poor G; Raspe HH; Reid DM; Reisinger W; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Reeve J;
    Osteoporos Int; 2003 Jan; 14(1):19-26. PubMed ID: 12577181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalent vertebral deformity independently increases incident vertebral fracture risk in middle-aged and elderly Japanese women: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Kadowaki E; Tamaki J; Iki M; Sato Y; Chiba Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
    Osteoporos Int; 2010 Sep; 21(9):1513-22. PubMed ID: 19924494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study.
    Kaptoge S; Armbrecht G; Felsenberg D; Lunt M; Weber K; Boonen S; Jajic I; Stepan JJ; Banzer D; Reisinger W; Janott J; Kragl G; Scheidt-Nave C; Felsch B; Matthis C; Raspe HH; Lyritis G; Póor G; Nuti R; Miazgowski T; Hoszowski K; Armas JB; Vaz AL; Benevolenskaya LI; Masaryk P; Cannata JB; Johnell O; Reid DM; Bhalla A; Woolf AD; Todd CJ; Cooper C; Eastell R; Kanis JA; O'Neill TW; Silman AJ; Reeve J
    Osteoporos Int; 2006; 17(9):1369-81. PubMed ID: 16821002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
    J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risk of incident vertebral fractures.
    Cauley JA; Hochberg MC; Lui LY; Palermo L; Ensrud KE; Hillier TA; Nevitt MC; Cummings SR
    JAMA; 2007 Dec; 298(23):2761-7. PubMed ID: 18165669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture.
    Schousboe JT; Fink HA; Lui LY; Taylor BC; Ensrud KE
    J Bone Miner Res; 2006 Oct; 21(10):1557-64. PubMed ID: 16995810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50.
    Naves M; Díaz-López JB; Gómez C; Rodríguez-Rebollar A; Cannata-Andía JB
    Osteoporos Int; 2005 Dec; 16(12):2013-7. PubMed ID: 16091836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of raloxifene on fracture severity in postmenopausal women with osteoporosis: results from the MORE study. Multiple Outcomes of Raloxifene Evaluation.
    Siris E; Adachi JD; Lu Y; Fuerst T; Crans GG; Wong M; Harper KD; Genant HK
    Osteoporos Int; 2002 Nov; 13(11):907-13. PubMed ID: 12415439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.